Drug survival of Adalimumab biosimilar vs Adalimumab originator in Hidradenitis Suppurativa: can equivalence be assumed? A retrospective cohort study.
Mercè Grau-PerezLaura Rodríguez-AguilarGaston RoustanFernando AlfagemePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)